🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Nestlé lifts Q2 RIG to 1.8% and prices Peranel water JV with Platinum Equity at CHF 4.5bn

Nestlé lifts Q2 RIG to 1.8% and prices its Peranel water JV at CHF 4.5B, netting CHF 2.8B at H1 2027 close as held-for-sale write-downs cut profit 31%.

Nestlé S.A. (SIX: NESN; OTCMKTS: NSRGY) used its H1 2026 results on 23 July to pair a modest but visibly improving underlying performance with the most decisive portfolio move of chief executive officer Philipp Navratil’s tenure. The Vevey-based group reported organic growth of 3.6% for the first half and 3.7% in Q2, with real internal growth accelerating to 1.8% in the second quarter from 1.2% in Q1, and on the same day announced Peranel, a 50:50 joint venture with Platinum Equity that carves out the entire waters and premium beverages business at an enterprise value of EUR 4.9 billion (CHF 4.5 billion). Behind the headlines, reported net profit fell 31.4% to CHF 3.472 billion, dragged down by a CHF 1.3 billion non-cash write-down on assets now classified as held for sale, while free cash flow rose 46.3% to CHF 3.375 billion. The share responded by touching a fresh 52-week high on the Six Swiss Exchange, closing the previous session at CHF 84.28 and trading intraday between CHF 85.20 and CHF 87.09. The central tension for shareholders is now cleanly framed: the RIG-led growth strategy is producing the volume improvement Nestlé has been promising, and the Peranel deal removes a structurally lower-margin category from the portfolio, but the group must still deliver against a heavier net debt load, a 6.2% foreign exchange headwind and the execution risk of a much more concentrated four-category business.

What did Nestlé’s H1 2026 results actually show about the RIG-led growth strategy Philipp Navratil is running?

The headline organic growth number of 3.6% for the first half sits inside Nestlé’s 3% to 4% guidance range for the year, but the composition is more important than the level. RIG, the volume and mix component that excludes pricing, was 1.5% for H1 and 1.8% in Q2, up from 0.2% in the same half a year earlier and clearly progressing toward the medium-term target of 2% or above that Nestlé has set for itself. Pricing was 2.1% for the half and 1.9% in Q2, moderating as last year’s coffee and cocoa-driven increases roll off. The Q2 result was positive across every zone, every globally managed business and every product category, which is the first time in several halves that Nestlé can claim broad-based real growth rather than a headline number carried by one or two categories.

The category breakdown reinforces that reading. Coffee delivered organic growth of 7.5% in H1 with 2.9% RIG, driven principally by Nescafé and Starbucks Coffee At Home. Food & Snacks grew 3.7% with RIG of 1.9%, supported by Nestlé’s billionaire brands Maggi, KitKat and Milo. Petcare organic growth of 2.7% masks a sequential improvement in dog food after several quarters of category softness in the United States. Nutrition remains the weak point, contracting 1.2% because of the infant formula recall that management confirms cost approximately 90 basis points of group organic growth in Q1 and 30 basis points in Q2. Nestlé expects to regain the lost infant formula share by year-end, which would remove roughly a full-year drag as it laps.

How does the Peranel joint venture with Platinum Equity change the shape of Nestlé’s remaining portfolio?

Peranel is the vehicle that formalises Nestlé’s long-signalled pivot toward four core categories. The 50:50 joint venture takes the entire Nestlé Waters & Premium Beverages segment, more than 30 brands sold in 120 countries, including S.Pellegrino, Source Perrier, Acqua Panna, Nestlé Pure Life, Sanpellegrino and Maison Perrier. Peranel will be headquartered in Paris and led by Muriel Lienau, currently chief executive officer of the segment, and it retains an in-house research and development team that has contributed to approximately 120 launches since 2022. Platinum Equity, a global investment firm with approximately USD 48 billion of assets under management, brings capital, corporate-carve-out experience and stated intent to pursue additional mergers and acquisitions inside the perimeter through managing director Igor Chacartegui and co-president Louis Samson.

The strategic logic runs in two directions. For Nestlé, water and premium beverages was the lowest-margin segment in the disclosed portfolio, generating an underlying trading operating profit margin of just 9.5% in H1 2026 compared with 21.4% in Zone Asia, Oceania and Africa and 20.7% at Nespresso. Removing that mix from group reporting mechanically supports the overall margin trajectory and lets management redirect executive attention and marketing spend toward Coffee, Petcare, Nutrition and Food & Snacks, the four categories where Nestlé holds structural market positions. For Platinum Equity, Peranel is a pure-play global mineral water asset acquired at a moment when premium hydration is one of the fastest-growing consumer beverage sub-categories, and it comes with a founder-independent management team already in place.

See also  Barry Callebaut Wieze chocolate factory hit by salmonella contamination

Why does the CHF 2.8 billion in cash proceeds matter more than the CHF 4.5 billion Peranel valuation?

The two numbers that most investors are focused on are the enterprise value of EUR 4.9 billion and the cash proceeds to Nestlé of approximately EUR 3.0 billion, or CHF 2.8 billion, at closing in H1 2027. On the CHF 1,781 million of segment sales Nestlé reported for H1 2026, an annualised run-rate near CHF 3.6 billion implies an enterprise-value multiple of roughly 1.25x sales, which sits well below the multiples that pure-play premium mineral water brands have historically attracted. The counter-argument is the segment’s 9.5% margin and the reality that Nestlé retains 50% of any future value creation inside Peranel, meaning the headline enterprise value is not the whole picture. If Peranel’s dedicated management, its 120-launch innovation pipeline and Platinum Equity’s mergers and acquisitions capability lift margins into the mid-teens over the next three to four years, Nestlé’s residual 50% stake becomes materially more valuable than the cash portion.

The cash proceeds are what allow investors to score the transaction against the H1 2026 balance sheet. Net debt was CHF 56.3 billion at 30 June 2026, up from CHF 51.4 billion at year-end 2025 primarily because of the CHF 8.0 billion dividend paid during the half. The CHF 2.8 billion Peranel inflow, added to a stated free cash flow expectation of above CHF 9 billion for the full year, gives Nestlé room to move on both dividend continuity and the smaller add-on transactions Navratil has signalled for the four core categories, without pushing the leverage ratio into territory that would attract credit-rating concern.

What is behind the 31% drop in Nestlé’s H1 net profit and does it change the underlying picture?

The reported net profit line looks alarming in isolation. Group net profit fell 31.4% to CHF 3.472 billion, basic earnings per share dropped 31.4% to CHF 1.35, and the reported operating profit margin contracted by 380 basis points to 11.6%. The two mechanical drivers are almost entirely non-operational. First, a CHF 1.3 billion non-cash write-down was booked as the mainstream vitamins, minerals and supplements business and the ice cream business were reclassified as assets held for sale, in preparation for their own sale processes. Second, restructuring and net other trading items rose to CHF 0.8 billion from CHF 0.4 billion, reflecting the acceleration of the Fuel for Growth cost-saving programme.

The underlying earnings per share number of CHF 2.22 is only 2.4% below prior year on a reported basis and up 3.4% in constant currency. The underlying trading operating profit margin held at 16.4%, down just 10 basis points reported and flat in constant currency, with tariff headwinds, higher coffee and cocoa input costs and the infant formula recall offset by pricing, cost savings and volume leverage. The sequential shape is more encouraging than the year-on-year comparison implies: H2 2025 underlying trading operating profit margin was 15.7%, and management now guides H2 2026 to be broadly similar to H1’s 16.4%, which delivers full-year improvement versus 2025. Free cash flow of CHF 3.375 billion was up 46.3%, reflecting lower capital expenditure and a smaller working-capital outflow, and gives credibility to the above-CHF 9 billion full-year target.

How are Nestlé’s operating zones and globally managed businesses actually performing beneath the group numbers?

Zone Asia, Oceania and Africa was the standout performer, delivering H1 organic growth of 4.3% and Q2 organic growth of 6.5%, with RIG accelerating to 4.8% in the second quarter. Excluding Greater China, the zone posted 7.7% organic growth on 6.0% RIG. India, Central and West Africa, and Indonesia all delivered double-digit RIG-led growth, and Greater China moved to a stable 2.0% organic growth line, confirming that the planned trade-inventory reduction and demand-led operating-model transition have now cycled through. Zone Americas delivered 3.3% organic growth on 1.0% RIG for H1, with Latin American markets Mexico and Brazil driving RIG acceleration and the United States showing resilient performance in Coffee and Petcare despite subdued consumer confidence. Zone Europe was the weakest, at 2.7% organic growth and just 0.5% RIG, held back by the infant formula recall and temporary retailer delistings, with only Türkiye, the United Kingdom and Ireland, and South and Eastern Europe contributing positively.

See also  Coffee Holding relaunches Harmony Bay Coffee brand

Nespresso posted organic growth of 4.3% for the half and 3.4% in Q2, with the underlying trading operating profit margin contracting 120 basis points to 20.7% on higher coffee input costs and increased marketing investment behind consumer acquisition, particularly in North America. Nestlé Waters & Premium Beverages, the business now being carved into Peranel, actually accelerated to 6.6% organic growth in Q2 with margin expansion of 20 basis points, meaning Nestlé is exiting the business into a joint venture on rising rather than falling operational momentum.

What signal does the yfood, Blue Bottle Coffee, held-for-sale ice cream and VMS activity send to shareholders?

Peranel is the largest but not the only portfolio move Navratil disclosed. Nestlé completed the acquisition of the remaining 51% ownership in yfood Labs GmbH, a Munich-based smart food and functional nutrition brand that generated approximately EUR 150 million in 2025 sales at double-digit year-on-year growth, giving Nestlé full control of a European brand aimed at the meal replacement and functional beverage occasions. On the divestment side, Nestlé sold Blue Bottle Coffee to Centurium Capital during H1, exiting a specialty coffee operator that had never scaled to justify its position in the group.

The classification of the mainstream vitamins, minerals and supplements business and the ice cream business as assets held for sale is the more consequential signal. It commits Nestlé publicly to exit both categories, means the sale processes are advanced enough to trigger the CHF 1.3 billion non-cash write-down against expected disposal proceeds, and reinforces that the four core categories the group will run are Coffee, Petcare, Nutrition and Food & Snacks, with Nespresso retained as a distinct globally managed business. The Fuel for Growth cost programme, which delivered CHF 0.6 billion of incremental savings in H1 to bring the cumulative total to CHF 1.7 billion, is running slightly ahead of the interim CHF 2.0 billion 2026 target, with the full CHF 3.0 billion by end-2027 now looking achievable.

What should investors track between now and the H1 2027 Peranel close to test the Nestlé execution thesis?

Peranel closing is subject to employee consultation processes and applicable regulatory approvals, with an expected closing in the first half of 2027, so the CHF 2.8 billion cash inflow does not hit the balance sheet in the current year. Investors should track four measurable proof points before then. RIG needs to hold above 1.5% and ideally reach 2% in H2 2026 to validate that Q2’s acceleration was not driven by one-off phasing. Underlying trading operating profit margin needs to land broadly similar to the H1 16.4% level in H2, delivering the promised full-year improvement over 2025’s 16.5% reported number. The infant formula recall needs to fully wash out of nutrition organic growth by Q4, restoring the category to positive contribution. And the parallel sale processes for mainstream vitamins, minerals and supplements and for ice cream need to reach binding agreements, since valuation slippage against the CHF 1.3 billion write-down assumption would put the reported profit line under further pressure.

The current-session market data supports a cautiously positive read on the H1 print. NESN traded intraday to CHF 87.09, marking a fresh 52-week high on the results day, on volume of over 5 million shares against a three-month average near 3.6 million. The consensus 12-month price target of CHF 88.19 leaves only limited upside on that basis, but the recent Jefferies upgrade to Buy at a CHF 99 target reflects the view that Peranel monetisation, Fuel for Growth delivery and RIG acceleration together deserve a rerating. Nestlé’s forward dividend yield of approximately 3.68% and its 24.6x trailing price-to-earnings multiple frame the stock as a defensive compounder rather than a value re-rating candidate, so incremental valuation upside depends on execution rather than multiple expansion.

See also  Sweet Oak acquires Whole Earth Brands with $862m financing from Silver Point Finance

What are the key takeaways for investors weighing Nestlé’s H1 2026 execution against the Peranel carve-out and portfolio reshape?

  • Nestlé S.A. reported H1 2026 organic growth of 3.6% and Q2 organic growth of 3.7%, with RIG accelerating to 1.8% in Q2 from 0.2% in the same half a year earlier, confirming that the RIG-led strategy Philipp Navratil is executing is producing broad-based volume and mix improvement across every zone and category.
  • Peranel, the newly announced 50:50 joint venture with Platinum Equity, values the entire Nestlé Waters & Premium Beverages business at an enterprise value of EUR 4.9 billion (CHF 4.5 billion), including S.Pellegrino, Source Perrier, Acqua Panna, Nestlé Pure Life and more than 30 brands sold in 120 countries.
  • Cash proceeds of approximately EUR 3.0 billion (CHF 2.8 billion) are expected at closing in H1 2027, subject to employee consultation processes and applicable regulatory approvals, giving Nestlé balance-sheet capacity to fund add-on activity in its four core categories while managing a net debt position that increased to CHF 56.3 billion at 30 June 2026.
  • The 31.4% drop in reported net profit to CHF 3.472 billion is driven by a CHF 1.3 billion non-cash write-down on the mainstream vitamins, minerals and supplements and ice cream businesses now classified as assets held for sale, and by higher Fuel for Growth restructuring costs, not by underlying operating deterioration.
  • Underlying earnings per share of CHF 2.22 fell only 2.4% on a reported basis but rose 3.4% in constant currency, and underlying trading operating profit margin held at 16.4%, flat in constant currency, indicating that tariffs, coffee and cocoa input inflation and the infant formula recall were absorbed by pricing, cost savings and volume leverage.
  • Free cash flow of CHF 3.375 billion for H1, up 46.3%, keeps the full-year target of above CHF 9 billion credible and gives Nestlé room to sustain the CHF 8.0 billion annual dividend without adding materially to leverage before the Peranel proceeds arrive.
  • Portfolio focus is now explicit: Nestlé will operate around Coffee, Petcare, Nutrition and Food & Snacks as its four core categories, retain Nespresso as a distinct globally managed business, exit water and premium beverages via Peranel, and complete the disposals of mainstream vitamins, minerals and supplements and ice cream.
  • The four measurable proof points for the thesis over the next four quarters are H2 2026 RIG sustaining above 1.5%, H2 underlying trading operating profit margin landing near the H1 16.4% level, infant formula returning to positive category growth by Q4 as the recall laps, and binding agreements on the vitamins, minerals and supplements and ice cream disposals at valuations close to the write-down assumption.
  • The share touched a fresh 52-week intraday high of CHF 87.09 on 23 July, above the CHF 84.28 previous close, on volume of over 5 million shares, indicating that the market has provisionally accepted the Peranel deal and the underlying RIG improvement as sufficient to look through the 31% reported profit drop, with the CHF 88.19 consensus 12-month target implying limited near-term upside absent further execution surprises.

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts